Medical Research

Mayo Clinic researchers identify molecule linked to treatment-resistant inflammatory bowel disease featured image
Research
Mayo Clinic researchers identify molecule linked to treatment-resistant inflammatory bowel disease

ROCHESTER, Minn. — Mayo Clinic researchers have identified an immune-regulating molecule that may help explain why some patients with inflammatory bowel disease (IBD), including Crohn’s[...]

Latest stories

Mayo Clinic researchers are building an early warning system for airborne viruses, bacteria, fungi and allergens featured image
Research
Mayo Clinic researchers are building an early warning system for airborne viruses, bacteria, fungi and allergens
Susan Murphy
October 20, 2026
Body composition changes on CT scans may help identify pancreatic cancer risk featured image
Cancer
Body composition changes on CT scans may help identify pancreatic cancer risk
Julie Ferris-Tillman, Ph.D.
October 20, 2026
GLP-1 drugs linked to lower kidney failure risk in bipolar disorder featured image
Research
GLP-1 drugs linked to lower kidney failure risk in bipolar disorder
Marla Broadfoot, Ph.D.
October 19, 2026
Large-scale study advances detection of DNA mutations across the human genome  featured image
Research
Large-scale study advances detection of DNA mutations across the human genome 
Susan Murphy
October 15, 2026
A shattered leg, a blood sample and a discovery that may have saved a family (VIDEO) featured image
Featured News
A shattered leg, a blood sample and a discovery that may have saved a family (VIDEO)
Susan Murphy
October 14, 2026
Mayo Clinic Minute: Unlocking how the liver regenerates after surgery (VIDEO) featured image
Cancer
Mayo Clinic Minute: Unlocking how the liver regenerates after surgery (VIDEO)
Brittany Cordeiro
October 14, 2026
One patient at a time, Mayo Clinic takes on the world’s rarest diseases  featured image
Research
One patient at a time, Mayo Clinic takes on the world’s rarest diseases 
Susan Murphy
October 13, 2026
FDA approves immunotherapy regimen studied by Mayo Clinic for stage 3 colon cancer featured image
Cancer
FDA approves immunotherapy regimen studied by Mayo Clinic for stage 3 colon cancer
Julie Ferris-Tillman, Ph.D.
October 9, 2026

Sign up to receive email notifications

Explore more topics

Sign up